Lipin-2 inhibitors represent a specific class of chemical compounds designed to modulate the activity of lipin-2, a member of the lipin family of proteins. Lipins play a crucial role in lipid metabolism, particularly in the regulation of triglyceride and phospholipid synthesis. Lipin-2, localized in the endoplasmic reticulum, functions as a phosphatidate phosphatase enzyme, catalyzing the conversion of phosphatidate to diacylglycerol, a key step in lipid biosynthesis. By inhibiting the activity of lipin-2, these inhibitors exert control over the intricate balance of lipid homeostasis.
Lipin-2 inhibitors stems from the recognition of the essential role lipin-2 plays in cellular lipid dynamics and its implications for various physiological processes. Researchers aim to elucidate the precise mechanisms through which lipin-2 inhibitors modulate lipid metabolism and how these alterations influence cellular functions. Understanding the structural and biochemical aspects of the interaction between lipin-2 and its inhibitors is crucial for the rational design and optimization of compounds within this class. Furthermore, exploring the physiological consequences of lipin-2 inhibition provides valuable insights into the broader regulatory network governing lipid metabolism. The quest for lipin-2 inhibitors underscores the significance of deciphering the molecular intricacies that govern lipid homeostasis and opens avenues for potential applications in diverse fields such as metabolic research and cellular biochemistry.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin can activate AMP-activated protein kinase (AMPK), which may subsequently influence LPIN2 activity due to the role of AMPK in lipid metabolism. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin inhibits HMG-CoA reductase, leading to altered lipid biosynthesis, which could affect LPIN2-related metabolic processes. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, as a precursor of NAD+/NADH, can influence cellular metabolism and indirectly affect pathways where LPIN2 is implicated. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Atorvastatin, another HMG-CoA reductase inhibitor, can impact cholesterol synthesis and potentially lipid pathways regulated by LPIN2. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin inhibits HMG-CoA reductase which may indirectly influence LPIN2's role in lipid metabolism by altering cholesterol synthesis. | ||||||